Yasmin Saad

426 total citations
25 papers, 168 citations indexed

About

Yasmin Saad is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Yasmin Saad has authored 25 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 20 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Yasmin Saad's work include Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (14 papers) and Hepatitis B Virus Studies (5 papers). Yasmin Saad is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (14 papers) and Hepatitis B Virus Studies (5 papers). Yasmin Saad collaborates with scholars based in Egypt, United States and Tunisia. Yasmin Saad's co-authors include Doa’a A. Saleh, Wahid Doss, Mohamed Said, Gamal Esmat, Wafaa Elakel, Magdy El‐Serafy, Samar K. Darweesh, Maissa El Raziky, Olfat Shaker and Abeer A. Bahnassy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and Nutrition and Cancer.

In The Last Decade

Yasmin Saad

22 papers receiving 164 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasmin Saad Egypt 9 117 103 31 18 17 25 168
Huanming Xiao China 9 174 1.5× 139 1.3× 34 1.1× 13 0.7× 15 0.9× 24 222
Berta Caballol Spain 6 176 1.5× 140 1.4× 25 0.8× 22 1.2× 34 2.0× 18 234
Katharina Wöran Austria 8 134 1.1× 133 1.3× 25 0.8× 8 0.4× 45 2.6× 18 203
Hui-Han Hu Taiwan 7 153 1.3× 113 1.1× 28 0.9× 19 1.1× 14 0.8× 7 193
Ashley L. Louie United States 3 85 0.7× 63 0.6× 68 2.2× 18 1.0× 14 0.8× 4 172
Shuyan Chen China 9 157 1.3× 152 1.5× 17 0.5× 7 0.4× 18 1.1× 29 235
Shang‐Chin Huang Taiwan 10 243 2.1× 186 1.8× 14 0.5× 19 1.1× 18 1.1× 35 292
Jonas Santol Austria 7 67 0.6× 76 0.7× 24 0.8× 9 0.5× 40 2.4× 30 152
Beatriz Ameigeiras Argentina 7 85 0.7× 69 0.7× 16 0.5× 10 0.6× 10 0.6× 12 114
Lifen Wang China 7 83 0.7× 57 0.6× 76 2.5× 6 0.3× 18 1.1× 17 180

Countries citing papers authored by Yasmin Saad

Since Specialization
Citations

This map shows the geographic impact of Yasmin Saad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasmin Saad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasmin Saad more than expected).

Fields of papers citing papers by Yasmin Saad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasmin Saad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasmin Saad. The network helps show where Yasmin Saad may publish in the future.

Co-authorship network of co-authors of Yasmin Saad

This figure shows the co-authorship network connecting the top 25 collaborators of Yasmin Saad. A scholar is included among the top collaborators of Yasmin Saad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasmin Saad. Yasmin Saad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saad, Yasmin, et al.. (2025). Triglyceride-glucose index as a biomarker to differentiate stroke etiologic subtypes: a hospital-based cross-sectional study. Biomarkers in Medicine. 19(1). 23–29. 1 indexed citations
2.
3.
4.
El‐Serafy, Magdy, Maissa El Raziky, Wafaa Elakel, et al.. (2023). Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease. Arab Journal of Gastroenterology. 24(1). 29–33.
5.
Omar, Mohamed, et al.. (2023). Fibroscan in Grading and Prediction of the Risk of Bleeding of Gastro-Esophageal Varices in HCV related Cirrhotic Patients. The Egyptian Journal of Hospital Medicine. 91(1). 5157–5161.
6.
Saad, Yasmin, et al.. (2021). Study of Adiponectin Promotor Methylation status in patients with Non Alcoholic Fatty Liver Disease. Benha Journal of Applied Sciences. 6(5). 105–107. 1 indexed citations
7.
Saad, Yasmin, et al.. (2021). Nutrition in Cancer Patients Positive for COVID-19; Case Series and a Systematic Review of Literature. Nutrition and Cancer. 74(2). 450–462. 4 indexed citations
8.
Darweesh, Samar K., et al.. (2019). The clinical usefulness of elastography in the evaluation of nonalcoholic fatty liver disease patients: A biopsy-controlled study. European Journal of Gastroenterology & Hepatology. 31(8). 1010–1016. 9 indexed citations
9.
Shousha, Hend Ibrahim, et al.. (2019). Simple predictors of nonresponse to direct-acting antivirals in chronic hepatitis C patients. European Journal of Gastroenterology & Hepatology. 32(8). 1017–1022. 7 indexed citations
10.
Said, Mohamed, et al.. (2018). High prevalence of HCV (GT4)-related TSH abnormality among 13402 Egyptian patients treated with direct acting antiviral therapy. Hepatology International. 12(2). 143–148. 3 indexed citations
11.
Said, Mohamed, et al.. (2018). Ritonavir-boosted paritaprevir, ombitasvir plus ribavirin could improve eGFR in patients with renal impairment and HCV: an Egyptian cohort. Expert Review of Gastroenterology & Hepatology. 13(1). 89–93. 2 indexed citations
12.
Saad, Yasmin, et al.. (2017). Prevalence of thyroid dysfunction among 21672 Egyptian patients with chronic HCV genotype IV. Journal of Hepatology. 66(1). S703–S704. 1 indexed citations
13.
14.
15.
Zekri, Abdel‐Rahman N., Ahmed Raafat, Abeer A. Bahnassy, et al.. (2014). Promotor methylation: Does it affect response to therapy in chronic hepatitis C (G4) or fibrosis?. Annals of Hepatology. 13(5). 518–524. 8 indexed citations
16.
Saad, Yasmin, Maissa El Raziky, Naglaa Zayed, et al.. (2013). Hepatitis C genotype 4 with normal transaminases: Correlation with fibrosis and response to treatment, a cohort Egyptian study of 4277 patients. Clinics and Research in Hepatology and Gastroenterology. 37(5). 479–484. 7 indexed citations
17.
Saad, Yasmin, et al.. (2013). Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4. European Journal of Gastroenterology & Hepatology. 25(8). 920–925. 16 indexed citations
18.
Saad, Yasmin. (2013). Liver Stiffness Measurement by Fibroscan Predicts the Presence and Size of Esophageal Varices in Egyptian Patients with HCV Related Liver Cirrhosis. SHILAP Revista de lepidopterología. 7(10). 2253–7. 25 indexed citations
19.
Saad, Yasmin, et al.. (2013). New genetic markers for diagnosis of hepatitis C related hepatocellular carcinoma in Egyptian patients.. PubMed. 22(4). 419–25. 16 indexed citations
20.
Said, Mohamed, Mona S. El‐Raziky, Yasmin Saad, et al.. (2011). Impact of past HBV exposure on virological response to combined interferon ribavirin therapy in patients with chronic HCV genotype 4. 1(2). 38–43. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huanming Xiao Breakdown of academic impact, for papers by Berta Caballol Breakdown of academic impact, for papers by Katharina Wöran Breakdown of academic impact, for papers by Hui-Han Hu Breakdown of academic impact, for papers by Ashley L. Louie Breakdown of academic impact, for papers by Shuyan Chen Breakdown of academic impact, for papers by Shang‐Chin Huang Breakdown of academic impact, for papers by Jonas Santol Breakdown of academic impact, for papers by Beatriz Ameigeiras Breakdown of academic impact, for papers by Lifen Wang
Rankless by CCL
2026